Methazolamide
NDC Package 55806-021-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Methazolamide is a medication used to treat high pressure inside the eye due to certain types of glaucoma. Marketed by Effcon Laboratories, Inc., this product is identified by NDC 55806-021 and is authorized under FDA application ANDA040062.

Identification & Billing

NDC Package Code
55806-021-03
Package Description
100 TABLET in 1 BOTTLE, PLASTIC
Product Code
55806-021
11-Digit Billing Format
55806002103
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA

Clinical Specifications

Proprietary Name
Methazolamide
Dosage Form
-
Usage Information
This medication is used to treat high pressure inside the eye due to certain types of glaucoma. Lowering high pressure inside the eye helps to prevent blindness, vision loss, and nerve damage. Methazolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It works by decreasing the production of fluid inside the eye.

Regulatory & Marketing

Labeler Name
Effcon Laboratories, Inc.
FDA Application #
ANDA040062
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-14-1994
End Marketing Date
05-31-2022
Listing Expiration
05-31-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55806-021-03 identifies a specific commercial package of 100 tablet in 1 bottle, plastic of Methazolamide, labeled by Effcon Laboratories, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Effcon Laboratories, Inc. on July 14, 1994. The current certification is valid through May 31, 2022.

What are the primary indications for this medication?

This medication is used to treat high pressure inside the eye due to certain types of glaucoma. Lowering high pressure inside the eye helps to prevent blindness, vision loss, and nerve damage. Methazolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It works by decreasing the production of fluid inside the eye.

How is this Effcon Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55806002103. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55806-021-03
11-Digit CMS (5-4-2)
55806-0021-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.